Related Experiment Video
Updated: Feb 27, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
Obesity-related hypogonadism: a reversible condition
Stamatios Zouras1, Jeffrey W Stephens2, David Price1
1Department of Diabetes and Endocrinology, ABM University Health Board, Swansea, UK.
BMJ Case Reports
|June 25, 2017
Summary
Morbid obesity can cause hypogonadism. In a 30-year-old man, gastric bypass surgery reversed hypogonadism, normalizing testosterone levels and improving symptoms without further testosterone therapy.
Area of Science:
- Endocrinology
- Metabolic Syndrome
- Bariatric Surgery
Background:
- Obesity is frequently associated with hypogonadism, a condition characterized by low testosterone levels.
- The exact mechanisms linking obesity and hypogonadism are not fully understood, and the relationship may be bidirectional.
- Hypogonadotrophic hypogonadism presents with symptoms such as fatigue, decreased libido, and infertility.
Observation:
- A 30-year-old morbidly obese male patient presented with hypogonadotrophic hypogonadism.
- The patient underwent a Roux-en-Y gastric bypass procedure to address his obesity.
- He was receiving testosterone replacement therapy prior to the surgery.
Findings:
- Following bariatric surgery and significant weight loss, the patient's testosterone levels normalized.
- Symptoms associated with hypogonadism resolved, leading to the discontinuation of exogenous testosterone therapy.
- The case demonstrates a potential reversal of hypogonadism through surgical weight loss.
Implications:
- Weight loss, particularly following bariatric surgery, may restore gonadal function in obese individuals with hypogonadism.
- This finding suggests that obesity-induced hypogonadism might be a reversible condition.
- Further research into the metabolic and hormonal changes post-bariatric surgery is warranted to understand the mechanisms of gonadal function restoration.
Related Concept Videos
01:24Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
01:23Infertility in Males
620
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
620
01:20Disorders of the Male Reproductive System
5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
01:21Drug Dosing: Obese Patients
315
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
315
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
324
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
324
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
250
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
250